| UniProt ID | RRAGC_HUMAN | |
|---|---|---|
| UniProt AC | Q9HB90 | |
| Protein Name | Ras-related GTP-binding protein C | |
| Gene Name | RRAGC {ECO:0000312|HGNC:HGNC:19902} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 399 | |
| Subcellular Localization | Cytoplasm . Nucleus . Lysosome . Predominantly cytoplasmic. May shuttle between the cytoplasm and nucleus, depending on the bound nucleotide state of associated RRAGA (PubMed:11073942). | |
| Protein Description | Guanine nucleotide-binding protein forming heterodimeric Rag complexes required for the amino acid-induced relocalization of mTORC1 to the lysosomes and its subsequent activation by the GTPase RHEB. This is a crucial step in the activation of the TOR signaling cascade by amino acids.. | |
| Protein Sequence | MSLQYGAEETPLAGSYGAADSFPKDFGYGVEEEEEEAAAAGGGVGAGAGGGCGPGGADSSKPRILLMGLRRSGKSSIQKVVFHKMSPNETLFLESTNKIYKDDISNSSFVNFQIWDFPGQMDFFDPTFDYEMIFRGTGALIYVIDAQDDYMEALTRLHITVSKAYKVNPDMNFEVFIHKVDGLSDDHKIETQRDIHQRANDDLADAGLEKLHLSFYLTSIYDHSIFEAFSKVVQKLIPQLPTLENLLNIFISNSGIEKAFLFDVVSKIYIATDSSPVDMQSYELCCDMIDVVIDVSCIYGLKEDGSGSAYDKESMAIIKLNNTTVLYLKEVTKFLALVCILREESFERKGLIDYNFHCFRKAIHEVFEVGVTSHRSCGHQTSASSLKALTHNGTPRNAI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSLQYGAEE ------CCCCCCCCC | 24.95 | 25159151 | |
| 2 | Acetylation | ------MSLQYGAEE ------CCCCCCCCC | 24.95 | 20068231 | |
| 5 | Phosphorylation | ---MSLQYGAEETPL ---CCCCCCCCCCCC | 24.48 | 30108239 | |
| 10 | Phosphorylation | LQYGAEETPLAGSYG CCCCCCCCCCCCCCC | 18.33 | 29255136 | |
| 15 | Phosphorylation | EETPLAGSYGAADSF CCCCCCCCCCCCCCC | 18.13 | 29255136 | |
| 16 | Phosphorylation | ETPLAGSYGAADSFP CCCCCCCCCCCCCCC | 15.18 | 29255136 | |
| 21 | Phosphorylation | GSYGAADSFPKDFGY CCCCCCCCCCCCCCC | 38.43 | 29255136 | |
| 28 | Phosphorylation | SFPKDFGYGVEEEEE CCCCCCCCCCCHHHH | 20.28 | 28796482 | |
| 72 | Phosphorylation | LLMGLRRSGKSSIQK EEEECHHCCCCCCEE | 44.10 | 22673903 | |
| 75 | Phosphorylation | GLRRSGKSSIQKVVF ECHHCCCCCCEEEEE | 35.88 | 26699800 | |
| 76 | Phosphorylation | LRRSGKSSIQKVVFH CHHCCCCCCEEEEEE | 32.31 | 26699800 | |
| 79 | Ubiquitination | SGKSSIQKVVFHKMS CCCCCCEEEEEECCC | 38.40 | 21890473 | |
| 85 | Sulfoxidation | QKVVFHKMSPNETLF EEEEEECCCCCCEEE | 6.38 | 21406390 | |
| 86 | Phosphorylation | KVVFHKMSPNETLFL EEEEECCCCCCEEEE | 29.40 | 23927012 | |
| 90 | Phosphorylation | HKMSPNETLFLESTN ECCCCCCEEEEEECC | 29.47 | 23927012 | |
| 95 | Phosphorylation | NETLFLESTNKIYKD CCEEEEEECCCEECC | 39.15 | 29255136 | |
| 96 | Phosphorylation | ETLFLESTNKIYKDD CEEEEEECCCEECCC | 31.02 | 29255136 | |
| 100 | Phosphorylation | LESTNKIYKDDISNS EEECCCEECCCCCCC | 15.24 | 26434776 | |
| 137 | Phosphorylation | YEMIFRGTGALIYVI HHEEEECCCEEEEEE | 18.28 | 24043423 | |
| 142 | Phosphorylation | RGTGALIYVIDAQDD ECCCEEEEEEECCCH | 7.69 | 24043423 | |
| 150 | Phosphorylation | VIDAQDDYMEALTRL EEECCCHHHHHHHHH | 12.73 | 24043423 | |
| 151 | Sulfoxidation | IDAQDDYMEALTRLH EECCCHHHHHHHHHE | 2.90 | 30846556 | |
| 155 | Phosphorylation | DDYMEALTRLHITVS CHHHHHHHHHEEEEE | 37.93 | 24043423 | |
| 242 | Phosphorylation | KLIPQLPTLENLLNI HHHCCCCCHHHHHHH | 56.12 | 20068231 | |
| 252 | Phosphorylation | NLLNIFISNSGIEKA HHHHHHHCCCCHHHH | 17.75 | 20068231 | |
| 327 | Phosphorylation | LNNTTVLYLKEVTKF ECCCEEEEHHHHHHH | 16.05 | - | |
| 329 | Ubiquitination | NTTVLYLKEVTKFLA CCEEEEHHHHHHHHH | 36.26 | - | |
| 361 | Malonylation | YNFHCFRKAIHEVFE CCHHHHHHHHHHHHH | 31.29 | 26320211 | |
| 376 | Phosphorylation | VGVTSHRSCGHQTSA HCCCCCCCCCCCCCH | 21.01 | 30108239 | |
| 381 | Phosphorylation | HRSCGHQTSASSLKA CCCCCCCCCHHHHHH | 22.15 | 25849741 | |
| 382 | Phosphorylation | RSCGHQTSASSLKAL CCCCCCCCHHHHHHH | 21.42 | 25159151 | |
| 384 | Phosphorylation | CGHQTSASSLKALTH CCCCCCHHHHHHHHC | 35.65 | 27794612 | |
| 385 | Phosphorylation | GHQTSASSLKALTHN CCCCCHHHHHHHHCC | 33.34 | 23401153 | |
| 387 | Methylation | QTSASSLKALTHNGT CCCHHHHHHHHCCCC | 43.21 | 115977383 | |
| 390 | Phosphorylation | ASSLKALTHNGTPRN HHHHHHHHCCCCCCC | 20.39 | 30108239 | |
| 394 | Phosphorylation | KALTHNGTPRNAI-- HHHHCCCCCCCCC-- | 25.13 | 30266825 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RRAGC_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RRAGC_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SQSTM_HUMAN | SQSTM1 | physical | 21981924 | |
| RPTOR_HUMAN | RPTOR | physical | 21981924 | |
| RRAGB_HUMAN | RRAGB | physical | 21981924 | |
| MTOR_HUMAN | MTOR | physical | 21981924 | |
| RRAGA_HUMAN | RRAGA | physical | 21981924 | |
| RPTOR_HUMAN | RPTOR | physical | 18497260 | |
| LTOR1_HUMAN | LAMTOR1 | physical | 22424946 | |
| RRAGB_HUMAN | RRAGB | physical | 22424946 | |
| WNT2_HUMAN | WNT2 | physical | 21988832 | |
| RRAGB_HUMAN | RRAGB | physical | 24337580 | |
| RPTOR_HUMAN | RPTOR | physical | 24337580 | |
| MTOR_HUMAN | MTOR | physical | 24337580 | |
| RRAGD_HUMAN | RRAGD | physical | 24337580 | |
| RRAGA_HUMAN | RRAGA | physical | 24337580 | |
| RRAGA_HUMAN | RRAGA | physical | 20381137 | |
| RRAGB_HUMAN | RRAGB | physical | 20381137 | |
| LTOR3_HUMAN | LAMTOR3 | physical | 20381137 | |
| LTOR2_HUMAN | LAMTOR2 | physical | 20381137 | |
| LTOR1_HUMAN | LAMTOR1 | physical | 20381137 | |
| TSC2_HUMAN | TSC2 | physical | 24529380 | |
| TSC1_HUMAN | TSC1 | physical | 24529380 | |
| RPTOR_HUMAN | RPTOR | physical | 25446900 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND MASSSPECTROMETRY. | |